Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single-plex testing: WJOG13620L.
Uemura T, Kenmotsu H, Hazama D, Teraoka S, Kobe H, Azuma K, Yamaguchi T, Masuda T, Yokoyama T, Otsubo K, Haratani K, Hayakawa D, Oki M, Takemoto S, Ozaki T, Akashi Y, Hata A, Hashimoto H, Yamamoto N, Nakagawa K. Uemura T, et al. Among authors: hayakawa d. Cancer Med. 2023 Dec;12(23):21097-21110. doi: 10.1002/cam4.6668. Epub 2023 Nov 10. Cancer Med. 2023. PMID: 37948122 Free PMC article.
Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy.
Torasawa M, Horinouchi H, Nomura S, Igawa S, Asai M, Ishii H, Wakui H, Ushio R, Asao T, Namba Y, Koyama R, Hayakawa D, Katayama I, Matsuda H, Sasaki S, Takahashi K, Hosomi Y, Naoki K, Ohe Y. Torasawa M, et al. Among authors: hayakawa d. J Thorac Oncol. 2024 Feb;19(2):325-336. doi: 10.1016/j.jtho.2023.09.1446. Epub 2023 Sep 23. J Thorac Oncol. 2024. PMID: 37748690 Free article.
First Direct Observation of Collider Neutrinos with FASER at the LHC.
Abreu H, Anders J, Antel C, Ariga A, Ariga T, Atkinson J, Bernlochner FU, Blesgen T, Boeckh T, Boyd J, Brenner L, Cadoux F, Casper DW, Cavanagh C, Chen X, Coccaro A, Desai A, Dmitrievsky S, D'Onofrio M, Favre Y, Fellers D, Feng JL, Fenoglio CA, Ferrere D, Gibson S, Gonzalez-Sevilla S, Gornushkin Y, Gwilliam C, Hayakawa D, Hsu SC, Hu Z, Iacobucci G, Inada T, Jakobsen S, Joos H, Kajomovitz E, Kawahara H, Keyken A, Kling F, Köck D, Kose U, Kotitsa R, Kuehn S, Lefebvre H, Levinson L, Li K, Liu J, MacDonald J, Magliocca C, Martinelli F, McFayden J, Milanesio M, Mladenov D, Moretti T, Munker M, Nakamura M, Nakano T, Nessi M, Neuhaus F, Nevay L, Otono H, Pang H, Paolozzi L, Petersen B, Pietropaolo F, Prim M, Queitsch-Maitland M, Resnati F, Rokujo H, Ruiz-Choliz E, Sabater-Iglesias J, Sato O, Scampoli P, Schmieden K, Schott M, Sfyrla A, Shively S, Takubo Y, Tarannum N, Theiner O, Torrence E, Tufanli S, Vasina S, Vormwald B, Wang D, Welch E, Zambito S; FASER Collaboration. Abreu H, et al. Among authors: hayakawa d. Phys Rev Lett. 2023 Jul 21;131(3):031801. doi: 10.1103/PhysRevLett.131.031801. Phys Rev Lett. 2023. PMID: 37540863 Free article.
Mediastinal pancreatic pseudocyst diagnosed based on black pleural effusion.
Katayama I, Komatsu A, Watanabe T, Hayakawa D, Iwakami N, Genda T, Iwakami SI, Takahashi K. Katayama I, et al. Among authors: hayakawa d. Respirol Case Rep. 2023 Jul 25;11(8):e01195. doi: 10.1002/rcr2.1195. eCollection 2023 Aug. Respirol Case Rep. 2023. PMID: 37497338 Free PMC article.
A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy.
Takeda M, Shimokawa M, Nakamura A, Nosaki K, Watanabe Y, Kato T, Hayakawa D, Tanaka H, Takahashi T, Oki M, Tachihara M, Fujimoto D, Hayashi H, Yamaguchi K, Yamamoto S, Iwama E, Azuma K, Hasegawa K, Yamamoto N, Nakagawa K. Takeda M, et al. Among authors: hayakawa d. Lung Cancer. 2023 Mar;177:44-50. doi: 10.1016/j.lungcan.2023.01.011. Epub 2023 Jan 28. Lung Cancer. 2023. PMID: 36731290 Free article. Clinical Trial.
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
Shimamura SS, Shukuya T, Asao T, Hayakawa D, Kurokawa K, Xu S, Miura K, Mitsuishi Y, Tajima K, Shibayama R, Shimada N, Takahashi F, Takahashi K. Shimamura SS, et al. Among authors: hayakawa d. BMC Cancer. 2022 Mar 25;22(1):323. doi: 10.1186/s12885-022-09421-7. BMC Cancer. 2022. PMID: 35337281 Free PMC article.
157 results